Wei Tian, PhD, Director Formulation at Lonza

Wei Tian is an experienced pharmaceutical development professional and has achieved market authorization of several generic and NCE products in the EU and US. Many of these products were approved through the 505(b)2 application route, through reformulation and dosage changes.

Speaker Details